Skip to main content
Top
Published in: Indian Journal of Surgical Oncology 4/2018

01-12-2018 | Original Article

Etiologic and Clinicopathological Correlates of Gastric Carcinoma in the Egyptian Delta

Authors: Mohamed Farouk Akl, Mohamed Awad Ibrahem, Ashraf Khater, Eman El-zahaf, Kamel Farag, Heba Abdallah

Published in: Indian Journal of Surgical Oncology | Issue 4/2018

Login to get access

Abstract

We aimed at evaluation of the clinicoepidemiologic data of patients with gastric carcinoma in the Egyptian Delta as regards the etiologic factors, behavior, presenting symptoms, and tumor location, grade, and stage with highlighting of the treatment modalities, survival, and prognostic factors. Three hundred cases with gastric carcinoma were enrolled, diagnosed, and treated in a tertiary oncology center in the Egyptian Delta. Data were collected as regards the etiology, presenting symptoms, family history, comorbid conditions, treatment modalities, responses, recurrences, and survival outcomes. Univariate and multivariate analyses were done to correlate the different clinicopathologic factors with the overall and disease-free survivals. Male to female ratio was 2:1. The median age was 43 years. The main tumor location was in the gastric body. Pain was the commonest presenting symptom (36%). Most of the cases were stage IV (42.0%). Only 49% of cases were operable. On multivariate analysis, age more than 60 years, performance status 3–4, high grade, diffuse type, T4 lesions, N2 and N3, and the presence of metastasis were independently associated with worse OS. We report a clinic-epidemiologic study of gastric carcinoma in the Egyptian delta; the age at presentation was a decade earlier than that recorded in the USA and Europe; most of the cases were sporadic, located mostly at the body. Most of the cases were presented at stage IV with poor response to neoadjuvant therapy with a poorer overall survival than that recorded in the USA and Europe.
Literature
1.
go back to reference McGuire S (2016) World Cancer report 2014. Geneva, Switzerland: World Health Organization, International Agency for Research on Cancer, WHO Press, 2015. Adv Nutr 7(2):418–419CrossRef McGuire S (2016) World Cancer report 2014. Geneva, Switzerland: World Health Organization, International Agency for Research on Cancer, WHO Press, 2015. Adv Nutr 7(2):418–419CrossRef
2.
go back to reference La Vecchia C, Negri E, Franceschi S, Gentile A (1992) Family history and the risk of stomach and colorectal cancer. Cancer 70(1):50–55CrossRef La Vecchia C, Negri E, Franceschi S, Gentile A (1992) Family history and the risk of stomach and colorectal cancer. Cancer 70(1):50–55CrossRef
3.
go back to reference Hirohata T, Kono S. Diet/nutrition and stomach cancer in Japan.Int J Cancer. 1997;Suppl 10:34–36CrossRef Hirohata T, Kono S. Diet/nutrition and stomach cancer in Japan.Int J Cancer. 1997;Suppl 10:34–36CrossRef
4.
go back to reference Tsugane S, Sasazuki S. Diet and the risk of gastric cancer: review of epidemiological evidence. Gastric Cancer 2007;10(2):75–83CrossRef Tsugane S, Sasazuki S. Diet and the risk of gastric cancer: review of epidemiological evidence. Gastric Cancer 2007;10(2):75–83CrossRef
5.
go back to reference Ladeiras-Lopes R, Pereira AK, Nogueira A, et al. Smoking and gastric cancer: systematic review and meta-analysis of cohort studies. Cancer Causes Control 2008;19(7):689–701CrossRef Ladeiras-Lopes R, Pereira AK, Nogueira A, et al. Smoking and gastric cancer: systematic review and meta-analysis of cohort studies. Cancer Causes Control 2008;19(7):689–701CrossRef
6.
go back to reference Wong BC, Lam SK, Wong WM et al (2004) Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. J Am Med Assoc 291(2):187–194CrossRef Wong BC, Lam SK, Wong WM et al (2004) Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. J Am Med Assoc 291(2):187–194CrossRef
7.
go back to reference Neumann WL, Coss E, Rugge M, et al. Autoimmune atrophic gastritis: pathogenesis, pathology and management. Nat Rev Gastroenterol Hepatol . 2013;10(9):529–541CrossRef Neumann WL, Coss E, Rugge M, et al. Autoimmune atrophic gastritis: pathogenesis, pathology and management. Nat Rev Gastroenterol Hepatol . 2013;10(9):529–541CrossRef
8.
go back to reference Ahmad SA, Xia BT, Bailey CE, Abbott DE, Helmink BA, Daly MC, Thota R, Schlegal C, Winer LK, Ahmad SA, al Humaidi AH, Parikh AA (2016) An update on gastric cancer. Curr Probl Surg 53:449–490CrossRef Ahmad SA, Xia BT, Bailey CE, Abbott DE, Helmink BA, Daly MC, Thota R, Schlegal C, Winer LK, Ahmad SA, al Humaidi AH, Parikh AA (2016) An update on gastric cancer. Curr Probl Surg 53:449–490CrossRef
9.
go back to reference Wanebo HJ, Kennedy BJ, Chmiel J, Steele Jr G, Winchester D, Osteen R (1993) Cancer of the stomach. Ann Surg 218(5):583–592CrossRef Wanebo HJ, Kennedy BJ, Chmiel J, Steele Jr G, Winchester D, Osteen R (1993) Cancer of the stomach. Ann Surg 218(5):583–592CrossRef
10.
go back to reference Postlewait LM, Maithel SK (2016) The importance of surgical margins in gastric cancer. J Surg Oncol 113(3):277–282CrossRef Postlewait LM, Maithel SK (2016) The importance of surgical margins in gastric cancer. J Surg Oncol 113(3):277–282CrossRef
11.
go back to reference Akagi T, Shiraishi N, Kitano S (2011) Lymph node metastasis of gastric cancer. Cancers (Basel) 3(2):2141–2159CrossRef Akagi T, Shiraishi N, Kitano S (2011) Lymph node metastasis of gastric cancer. Cancers (Basel) 3(2):2141–2159CrossRef
12.
go back to reference Cunningham D, Allum WH, Stenning SP et al (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355(1):11–20CrossRef Cunningham D, Allum WH, Stenning SP et al (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355(1):11–20CrossRef
13.
go back to reference Kelley JR, Duggan JM (2003) Gastric cancer epidemiology and risk factors. COMMENTARY. J Clin Epidemiol 56:1–9CrossRef Kelley JR, Duggan JM (2003) Gastric cancer epidemiology and risk factors. COMMENTARY. J Clin Epidemiol 56:1–9CrossRef
14.
go back to reference Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90CrossRef Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90CrossRef
15.
go back to reference Khalifa MM, Sharaf RR, Aziz RK (2010) Helicobacter pylori: a poor man’s gut pathogen? Gut Pathogens 2:2CrossRef Khalifa MM, Sharaf RR, Aziz RK (2010) Helicobacter pylori: a poor man’s gut pathogen? Gut Pathogens 2:2CrossRef
16.
go back to reference Eslick GD, Lim LL, Byles JE et al (1999) Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis. Am J Gastroenterol 94(9):2373–2379CrossRef Eslick GD, Lim LL, Byles JE et al (1999) Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis. Am J Gastroenterol 94(9):2373–2379CrossRef
17.
go back to reference Xue F-B, Xu Y-Y, Wan Y, Pan B-R, Ren J, Fan D-M (2001) Association of H. Pylori infection with gastric carcinoma: a meta-analysis. World J Gastroenterol 7(6):801–804CrossRef Xue F-B, Xu Y-Y, Wan Y, Pan B-R, Ren J, Fan D-M (2001) Association of H. Pylori infection with gastric carcinoma: a meta-analysis. World J Gastroenterol 7(6):801–804CrossRef
18.
go back to reference IARC. Schistosomes, liver flukes and helicobacter pylori. IARC monographs of the evaluation of carcinogenic risks to humans 1994;61:177–241 IARC. Schistosomes, liver flukes and helicobacter pylori. IARC monographs of the evaluation of carcinogenic risks to humans 1994;61:177–241
19.
go back to reference Tobacco smoke and involuntary smoking. Lyon, France: World Health Organisation ; 2004 Tobacco smoke and involuntary smoking. Lyon, France: World Health Organisation ; 2004
20.
go back to reference Sjodahl K, Lu Y, Nilsen TI et al (2007) Smoking and alcohol drinking in relation to risk of gastric cancer: a population-based, prospective cohort study. Int J Cancer 120:128–132CrossRef Sjodahl K, Lu Y, Nilsen TI et al (2007) Smoking and alcohol drinking in relation to risk of gastric cancer: a population-based, prospective cohort study. Int J Cancer 120:128–132CrossRef
21.
go back to reference Barber M, Fitzgerald RC, Caldas C (2006) Familial gastric cancer—aetiology and pathogenesis. Best Pract Res Clin Gastroenterol 20:721–734CrossRef Barber M, Fitzgerald RC, Caldas C (2006) Familial gastric cancer—aetiology and pathogenesis. Best Pract Res Clin Gastroenterol 20:721–734CrossRef
22.
go back to reference Edge SB, Compton CC (2010) The American joint committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17(6):1471–1474CrossRef Edge SB, Compton CC (2010) The American joint committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17(6):1471–1474CrossRef
23.
go back to reference Akoh JA, Macintyre IM (1992) Improving survival in gastric cancer: review of 5-year survival rates in English language publications from 1970. Br J Surg 79:293–299CrossRef Akoh JA, Macintyre IM (1992) Improving survival in gastric cancer: review of 5-year survival rates in English language publications from 1970. Br J Surg 79:293–299CrossRef
Metadata
Title
Etiologic and Clinicopathological Correlates of Gastric Carcinoma in the Egyptian Delta
Authors
Mohamed Farouk Akl
Mohamed Awad Ibrahem
Ashraf Khater
Eman El-zahaf
Kamel Farag
Heba Abdallah
Publication date
01-12-2018
Publisher
Springer India
Published in
Indian Journal of Surgical Oncology / Issue 4/2018
Print ISSN: 0975-7651
Electronic ISSN: 0976-6952
DOI
https://doi.org/10.1007/s13193-018-0754-6

Other articles of this Issue 4/2018

Indian Journal of Surgical Oncology 4/2018 Go to the issue